Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Expenditures: 2015-2025

Historic Capital Expenditures for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $433,000.

  • Editas Medicine's Capital Expenditures fell 85.18% to $433,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 58.22%. This contributed to the annual value of $8.8 million for FY2024, which is 87.03% up from last year.
  • Latest data reveals that Editas Medicine reported Capital Expenditures of $433,000 as of Q3 2025, which was up 279.82% from $114,000 recorded in Q1 2025.
  • In the past 5 years, Editas Medicine's Capital Expenditures registered a high of $3.5 million during Q2 2024, and its lowest value of $114,000 during Q1 2025.
  • Its 3-year average for Capital Expenditures is $1.4 million, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, Editas Medicine's Capital Expenditures soared by 1,122.18% in 2024 and then plummeted by 93.91% in 2025.
  • Quarterly analysis of 5 years shows Editas Medicine's Capital Expenditures stood at $2.8 million in 2021, then plummeted by 78.07% to $624,000 in 2022, then spiked by 109.46% to $1.3 million in 2023, then tumbled by 58.68% to $540,000 in 2024, then tumbled by 85.18% to $433,000 in 2025.
  • Its last three reported values are $433,000 in Q3 2025, $114,000 for Q1 2025, and $540,000 during Q4 2024.